DAA1123 (50 mg)

Precursor for [¹¹C]DAA1106

Product No.: HMPA-95-0050

DAA1123

Product No.：HMPA-95

CAS No.：220553-37-7


Product Name:	DAA1123
Synonyms:	N-(5-fluoro-2-phenoxyphenyl)-N-(2-hydroxy-5-methoxybenzyl)acetamidee
CAS No.:	220553-37-7
Molecular Formula:	C₂₂H₂₀FNO₄
Molecular Weight:	381.40
Application:	Precursor for [¹¹C]DAA1106
Presentation:	Packaged in amber vial or amber screw cap vials with teflon-coated stoppers under argon atmosphere.

Note

Care must be taken when handling this product.
Do not contact skin or eyes.
Do not ingest or inhale.
Store at <-20℃. Protect from light.(Short-term storage (<1 month) at higher temperatures (e.g. during transport) does not affect product quality)
It shall be only used by qualified personnel.

Order Number

HMPA-95-0010x 10mg per vial
HMPA-95-0020x 20mg per vial
- note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial
- *Customized dispensing is available

Literature

Okuyama S, Chaki S, Yoshikawa R, Ogawa S, Suzuki Y, Okubo T, Nakazato A, Nagamine M, Tomisawa K (1999). "Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106". Life Sciences 64 (16): 1455–64.
Okubo T, Yoshikawa R, Chaki S, Okuyama S, Nakazato A (January 2004). "Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands". Bioorganic & Medicinal Chemistry 12 (2): 423–38.